Filing Details
- Accession Number:
- 0001209191-14-069065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-17 12:09:36
- Reporting Period:
- 2014-10-31
- Filing Date:
- 2014-11-17
- Accepted Time:
- 2014-11-17 12:09:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529196 | J Mark Foley | 4698 Willow Road Suite 100 Pleasanton CA 94588 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-10-31 | 1,150 | $0.00 | 578,883 | No | 5 | G | Direct | |
Common Stock | Disposition | 2014-11-03 | 1,940 | $0.00 | 576,943 | No | 5 | G | Direct | |
Common Stock | Disposition | 2014-11-13 | 4,666 | $26.77 | 572,277 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-11-14 | 7,123 | $26.92 | 565,154 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the number of shares withheld by and surrendered to the Issuer on November 14, 2014, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU grant on August 23, 2012 of 286,215 shares. The initial grant vests in five equal installments, each on the first date that the weighted average stock price of ZELTIQ Common Stock during the immediately preceding 90-day period is $10 or more, $15 or more, $20 or more, $25 or more, and $30 and more, respectively.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 17, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.48 to $27.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.